Ferring opens doors to Finnish manufacturing hub as supply of its bladder cancer gene therapy continues to grow fkansteiner Thu, 10/03/2024 – 12:12 More: Ferring opens doors to Finnish manufacturing hub as supply of its bladder cancer gene therapy continues
read moreArgenx widens its Halozyme Therapeutics-partnered net with 4 new targets in $30M license expansion zbecker Thu, 10/03/2024 – 10:54 More: Argenx widens its Halozyme Therapeutics-partnered net with 4 new targets in M license expansion Source: fierce
read moreEliem Therapeutics mounts corporate rebrand after pipeline overhaul, mass layoffs apark Thu, 10/03/2024 – 10:50 More: Eliem Therapeutics mounts corporate rebrand after pipeline overhaul, mass layoffs Source: fierce
read more
Phase 1 trial of IRL757 demonstrates good absorption and safety profile More: IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients Source: News
read more
Largest real-world study demonstrates significant survival advantage More: ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study Source: News
read moreGilead strikes licensing deals with 6 generics makers to boost access to long-acting HIV PrEP med zbecker Wed, 10/02/2024 – 14:33 More: Gilead strikes licensing deals with 6 generics makers to boost access to long-acting HIV PrEP med Source: fierce
read more© 1994 - 2025 B.M. Pharmaceuticals